MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Onset-related subtypes of Parkinson’s disease differ in the patterns of striatal functional connectivity: A resting-state functional MRI study

    Y. Hou, J. Yang, C. Luo, R. Ou, W. Song, Q. Gong, H. Shang (Chengdu, People's Republic of China)

    Objective: No. Background: Parkinson's disease is a surprising heterogeneous neurodegenerative disorder. Early onset Parkinson's disease (EOPD) and late onset Parkinson's disease (LOPD) were reported to…
  • 2016 International Congress

    Improvement of saccade amplitude by the STN DBS and visual target eccentricity

    A. Yugeta, Y. Terao, Y. Ugawa (Tokyo, Japan)

    Objective: To investigate whether or not the improvement of saccade amplitude by the subthalamic nucleus (STN) deep brain stimulation (DBS) is the same for to…
  • 2016 International Congress

    Impact of datscan on clinical decision making: diagnosis and management of clinically uncertain Parkinsonian syndromes

    J.R. Isaacson, N. Chhabria, S.H. Isaacson (Boca Raton, FL, USA)

    Objective: To assess changes in clinical diagnosis and/or treatment of 200 consecutive patients with clinically uncertain Parkinsonian syndromes who underwent DaTscan imaging with ioflupane for…
  • 2016 International Congress

    Neuropsychology and magnetic resonance correlation in Parkinson´s disease mild cognitive impairment: Case-control study

    L.F.R. Vasconcellos, M. Adachi, D. Greca, M. Cruz, A.L. Malak, H. Charchat-Fichman, J.S. Pereira (Rio de Janeiro, Brazil)

    Objective: Evaluate the relationship between magnetic resonance (MRI) abnormalities and neuropsychological assessment in Parkinson s disease mild cognitive impairment (PD-MCI) and controls with mild cognitive…
  • 2016 International Congress

    Prevalence of depression and dementia in Parkinson’s disease

    A. Kalendarev, F. Yunusov, G. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: The aim of this study was to estimate the prevalence of depressive and dementia symptoms in PD patients. Background: Parkinson's disease (PD) is a…
  • 2016 International Congress

    Defective visual perception in patients with Parkinson’s disease: The impairment of preattentive visual processing in the normal intellectual patients

    Y. Higashi, T. Tabuchi, M. Tabata, E. Mori (Himeji, Japan)

    Objective: In the previous conference, we reported that the impairment of preattentive visual processing could be detected even among subjects considered to have normal cognitive…
  • 2016 International Congress

    Assessment of humor in Parkinson’s disease and the effect of deep brain stimulation

    A. Greuel, C.J. Lewis, F. Maier, R. Dano, S. Heintz, W. Ruch, C. Eggers (Cologne, Germany)

    Objective: To assess humor perception in Parkinson's disease (PD) patients by comparison to a matched sample of healthy controls (HC), and to investigate the effects…
  • 2016 International Congress

    Are limbic and cognitive effects on balance in Parkinson’s disease equal?

    K.A. Ehgoetz Martens, C.G. Ellard, Q.J. Almeida (Camperdown, Australia)

    Objective: The main objective of this study was to evaluate: (i)whether highly anxious PD (HA-PD) have a reduced capacity for information processing compared to PD…
  • 2016 International Congress

    Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases

    H. Schmitz-Peiffer, K. Linse, W. Rüger, M. Joos, M. Löhle, A. Storch, A. Hermann (Dresden, Germany)

    Objective: To develop and evaluate motor-free procedures via eye tracking for determining cognitive functions in patients with idiopathic Parkinson's disease (PD) and motor neuron disease…
  • 2016 International Congress

    Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

    M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)

    Objective: To evaluate utility of the DRS-II Total Score for stratifying cognitive status in PD patients without frank cognitive impairment. Background: The DRS-II, a screening…
  • « Previous Page
  • 1
  • …
  • 149
  • 150
  • 151
  • 152
  • 153
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley